https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/accounts-payable https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/accounts-receivable https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/accrued-professional-fees-current https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/accumulated-depreciation https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/additional-paid-in-capital https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/aoci https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/asset-impairment-charges https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/assets-held-for-sale-not-part-of-disposal-group-current https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/assets-of-disposal-group-including-discontinued-operation https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/assets-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/basic-shares https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/capital-expenditures https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/cash-and-equivalents https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/cash-and-restricted-cash-including-disposal-group-and-discontinued-operations https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/cash-divested-from-deconsolidation https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/cash-flow-breakdown https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/comprehensive-income https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/contractual-obligation https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/contractual-obligation-due-after-fifth-year https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/contractual-obligation-due-in-fourth-and-fifth-year https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/contractual-obligation-due-in-next-twelve-months https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/contractual-obligation-due-in-second-and-third-year https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/contractual-obligation-future-minimum-payments-due-remainder-of-fiscal-year https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/cover-page-shares-outstanding https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/current-assets https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/current-liabilities https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/deferred-tax-assets-gross https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/deferred-tax-assets-net https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/deferred-tax-assets-other https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/depreciation https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/depreciation-and-amortization https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/diluted-shares https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/disposal-group-including-discontinued-operation-accounts-payable-current https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/disposal-group-including-discontinued-operation-cash-and-cash-equivalents https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/disposal-group-including-discontinued-operation-consideration https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/disposal-group-including-discontinued-operation-other-noncurrent-assets https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/disposal-group-including-discontinued-operation-prepaid-and-other-assets-current https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/disposal-group-including-discontinued-operation-property-plant-and-equipment-noncurrent https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/dividends-declared https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/employee-related-liabilities-current https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/eps https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/eps-basic https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/federal-income-tax-expense-benefit https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/financing-cash-flow https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/foreign-pretax-income https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/gain-loss-on-contract-termination https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/gain-loss-on-sale-of-business https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/gain-loss-on-termination-of-lease https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/gain-loss-related-to-litigation-settlement https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/general-and-administrative-expense https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/income-tax https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/income-tax-examination-penalties-and-interest-accrued https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/income-taxes-paid https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/interest-income-expense-nonoperating-net https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/interest-income-other https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/investing-cash-flow https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/lease-cost https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/liabilities-of-disposal-group-including-discontinued-operation https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/liabilities-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/loss-in-period https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/net-change-in-cash https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/net-income https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/new-shares-sold https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/noncurrent-assets https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/oci-foreign-currency-transaction-and-translation-gain-loss-arising-net-of-tax https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/oci-foreign-currency-transaction-and-translation-reclassification-adjustment-from-aoci-realized-upon-sale-or-liquidation-net-of-tax https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/operating-cash-flow https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/operating-expenses https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/operating-income https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/operating-lease-assets https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/operating-lease-expense https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/operating-lease-liability https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/operating-lease-liability-current https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/operating-lease-payments https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/operating-lease-payments-due https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/operating-lease-payments-due-current https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/operating-lease-payments-due-in-four-and-five-years https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/operating-lease-payments-due-in-two-and-three-years https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/operating-loss-carryforwards https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/other-accrued-liabilities-current https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/other-current-assets https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/other-income https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/other-noncurrent-assets https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/other-nonoperating-expense https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/other-nonoperating-income https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/other-nonoperating-income-expense https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/payments-for-restructuring https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/payments-of-financing-costs https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/preferred-shares-facts https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/preferred-stock-dividends-and-other-adjustments https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/preferred-stock-shares-issued https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/preferred-stock-value https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/prepaid-insurance https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/prepaid-taxes https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/pretax-income https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/pretax-income-domestic https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/proceeds-from-divestiture-of-businesses-net-of-cash-divested https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/proceeds-from-issuance-of-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/proceeds-from-sale-of-machinery-and-equipment https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/proceeds-from-stock-issued https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/proceeds-from-stock-plans https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/profit-loss https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/property-plant-equipment https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/purchase-obligation https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/purchase-obligation-due-after-fifth-year https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/purchase-obligation-due-in-fourth-and-fifth-year https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/purchase-obligation-due-in-fourth-year https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/purchase-obligation-due-in-next-twelve-months https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/purchase-obligation-due-in-second-and-third-year https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/purchase-obligation-due-in-second-year https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/purchase-obligation-due-in-third-year https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/purchase-obligation-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/related-party-transaction-selling-general-and-administrative-expenses-from-transactions-with-related-party https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/research-and-development https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/restricted-cash-and-cash-equivalents-noncurrent https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/restricted-cash-noncurrent https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/restructuring-and-related-cost-number-of-positions-eliminated https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/restructuring-and-related-cost-number-of-positions-eliminated-period-percent https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/restructuring-charges https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/restructuring-reserve https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/retained-earnings https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/revenue https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/severance-costs https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/shareholders-equity https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/shares-authorized https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/shares-issued https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/shares-issued-price-per-share https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/shares-outstanding-2 https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/short-term-lease-cost https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/stock-based-compensation https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/stock-split-ratio https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/sublease-income https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/supplemental-unemployment-benefits-severance-benefits https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/tax-reconciliation-other-reconciling-items https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/total-assets https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/total-liabilities https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/total-liabilities-and-equity https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/unrecognized-tax-benefits https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/value-added-tax-receivable-current https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/warrants-and-rights-outstanding https://stock.noler.com/us/stock/freeline-therapeutics-holdings-plc/weighted-average-number-of-share-outstanding-basic-and-diluted